Abstract: A micro-nutrient composition for a human subject suffering from a glaucomatous disease, wherein the micro-nutrient composition comprises a formulation for reversing mitochondrial dysfunction in glaucomatous disease. Formulations for improving outcomes based on resolving conditions at the cellular response level in certain individuals suffering from particular diseases. More particularly, the invention relates to compositions affecting the eye, such as glaucoma.

Abstract: Embodiments of the invention are directed toward neuroprotective formulations that may prevent the progression of glaucoma by strengthening the resistance of nerve cells to damage. Some embodiments of the invention are directed toward neuroprotective formulations that may limit and prevent glaucomatous damage by blocking the mechanisms that lead to retinal ganglion cell death. Other embodiments of the invention involve specific component formulations and methods of using the formulations.

Abstract: A method of permanently surgically treating glaucoma is disclosed together with an apparatus for effecting such treatment. In accordance with the method, an implant is disposed at a filtration site through the sclera the implant including a through going aperture leading from the anterior chamber to a bleb formed in the conjunctiva. The implant is retained in the sclera by radially compressing the same during the insertion procedure and thereafter releasing the radial compressive forces whereby the implant expands and is prevented from dislocation. An apparatus for effecting the implant is likewise disclosed, the apparatus including a cannula having a bore constraining the insert, a plunger for shifting the insert through an angularly offset opening in the cannula and a retainer filament engaged in the passage in the insert for controlling the precise location of the insert during the implant and for releasing the insert from connection to the cannula when the precise position is achieved.

Abstract: A method of permanently surgically treating glaucoma is disclosed together with an apparatus for effecting such treatment. In accordance with the method, an implant is disposed at a filtration site through the sclera the implant including a through going aperture leading from the anterior chamber to a bleb formed in the conjunctiva. The implant is retained in the sclera by radially compressing the same during the insertion procedure and thereafter releasing the radial compressive forces whereby the implant expands and is prevented from dislocation. An apparatus for effecting the implant is likewise disclosed, the apparatus including a cannula having a bore constraining the insert, a plunger for shifting the insert through an angularly offset opening in the cannula and a retainer filament engaged in the passage in the insert for controlling the precise location of the insert during the implant and for releasing the insert from connection to the cannula when the precise position is achieved.